Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response
Abstract With the continued promise of immunotherapy for treating cancer, understanding how host genetics contributes to the tumor immune microenvironment (TIME) is essential to tailoring cancer screening and treatment strategies. Here, we study 1084 eQTLs affecting the TIME found through analysis o...
Main Authors: | Meghana Pagadala, Timothy J. Sears, Victoria H. Wu, Eva Pérez-Guijarro, Hyo Kim, Andrea Castro, James V. Talwar, Cristian Gonzalez-Colin, Steven Cao, Benjamin J. Schmiedel, Shervin Goudarzi, Divya Kirani, Jessica Au, Tongwu Zhang, Teresa Landi, Rany M. Salem, Gerald P. Morris, Olivier Harismendy, Sandip Pravin Patel, Ludmil B. Alexandrov, Jill P. Mesirov, Maurizio Zanetti, Chi-Ping Day, Chun Chieh Fan, Wesley K. Thompson, Glenn Merlino, J. Silvio Gutkind, Pandurangan Vijayanand, Hannah Carter |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-05-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-023-38271-5 |
Similar Items
-
Germline DNA damage response gene mutations as predictive biomarkers of immune checkpoint inhibitor efficacy
by: Michael J. Dennis, et al.
Published: (2024-01-01) -
Somatic mutational profiles and germline polygenic risk scores in human cancer
by: Yuxi Liu, et al.
Published: (2022-02-01) -
Online Psychological Assessment for Children and Adolescents with Neurodevelopmental Disorders: Exploring New Avenues in Times of Social Distancing
by: Meghana Vijayanand, et al.
Published: (2022-03-01) -
COVID-19 genetic risk variants are associated with expression of multiple genes in diverse immune cell types
by: Benjamin J. Schmiedel, et al.
Published: (2021-11-01) -
Computer modeling describes gravity-related adaptation in cell cultures.
by: Ludmil B Alexandrov, et al.
Published: (2009-12-01)